Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Topics

Select Topic

Showing 102 results for "Myeloproliferative Neoplasms (MPN)".

Thumbnail for From Chronic to Blast: How Diagnostic Delay Shapes Outcomes in MLN-FGFR1

MPN - 1345

From Chronic to Blast: How Diagnostic Delay Shapes Outcomes in MLN-FGFR1

Mohammad Abu-Tineh

Poster Presenter: Mohammad Abu-Tineh

Thumbnail for Disparate Outcomes and Treatment Patterns in Polycythemia Vera Across an Integrated Academic-Community Network

MPN - 1384

Disparate Outcomes and Treatment Patterns in Polycythemia Vera Across an Integrated Academic-Community Network

Jessica Nino de Rivera

Poster Presenter: Jessica Nino de Rivera

Thumbnail for Frontline Systemic Therapeutic Patterns and Outcomes in Rosai-Dorfman Disease: A Multicenter Retrospective Analysis

Previous 1 2 3 4 5 6 7 8...12 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

MPN - 1474

Frontline Systemic Therapeutic Patterns and Outcomes in Rosai-Dorfman Disease: A Multicenter Retrospective Analysis

Aishwarya Pradeep

Poster Presenter: Aishwarya Pradeep

Thumbnail for Disease-Modifying Potential of Ropeginterferon Alfa-2b Across Myeloproliferative Neoplasms: A Systematic Review and Meta-Analysis

MPN - 1568

Disease-Modifying Potential of Ropeginterferon Alfa-2b Across Myeloproliferative Neoplasms: A Systematic Review and Meta-Analysis

Anubhuti Sharma

Poster Presenter: Anubhuti Sharma

Thumbnail for Benefit of Rusfertide Maintained in Patients With Low-Risk or High-Risk Polycythemia Vera: Efficacy and Safety Subgroup Analysis From the Randomized Controlled Phase 3 VERIFY Study

MPN - 161

Benefit of Rusfertide Maintained in Patients With Low-Risk or High-Risk Polycythemia Vera: Efficacy and Safety Subgroup Analysis From the Randomized Controlled Phase 3 VERIFY Study

Naveen Pemmaraju

Poster Presenter: Naveen Pemmaraju

Thumbnail for Targeting Metabolic-Inflammatory Signaling in Chronic Myelomonocytic Leukemia: Association of GLP-1 Receptor Agonist Therapy with Improved Real-World Outcomes

MPN - 1634

Targeting Metabolic-Inflammatory Signaling in Chronic Myelomonocytic Leukemia: Association of GLP-1 Receptor Agonist Therapy with Improved Real-World Outcomes

Asfand Yar Cheema

Poster Presenter: Asfand Yar Cheema

Thumbnail for Socioeconomic and Geographic Disparities in Survival Outcomes Among Patients with Chronic Myelomonocytic Leukemia: A SEER-Based Analysis

MPN - 1641

Socioeconomic and Geographic Disparities in Survival Outcomes Among Patients with Chronic Myelomonocytic Leukemia: A SEER-Based Analysis

Mishaal Munir

Poster Presenter: Mishaal Munir

Thumbnail for KIT D816V-Selective Tyrosine Kinase Inhibitors for the Treatment of Advanced Systemic Mastocytosis: A Systematic Review and Meta-Analysis of Efficacy and Safety Outcomes

MPN - 1664

KIT D816V-Selective Tyrosine Kinase Inhibitors for the Treatment of Advanced Systemic Mastocytosis: A Systematic Review and Meta-Analysis of Efficacy and Safety Outcomes

Abdullah Ali

Poster Presenter: Abdullah Ali

Thumbnail for Hypocellular Bone Marrow as an Independent Adverse Prognostic Feature in Primary Myelofibrosis: A Real-World Analysis of 241 Patients

MPN - 1673

Hypocellular Bone Marrow as an Independent Adverse Prognostic Feature in Primary Myelofibrosis: A Real-World Analysis of 241 Patients

Elmir Guluyev

Poster Presenter: Elmir Guluyev

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors